waypoint wealth counsel
Source: SEC Form 13F · as of Mar 2026waypoint wealth counsel holds 18 biotech & pharma companies tracked by BioSniper, totaling $8.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$8.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 5,621 | $1.4M |
| MRKMerck & Co., Inc. | 9,896 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 15,620 | $947K |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,085 | $838K |
| GMOptec International, Inc. | 9,105 | $678K |
| INCYIncyte Corp. | 6,345 | $597K |
| LLYELI LILLY & Co | 464 | $427K |
| MEDPMedpace Holdings Inc. | 844 | $405K |
| NBIXNEUROCRINE BIOSCIENCES INC | 2,869 | $378K |
| ABBVAbbVie Inc. | 1,601 | $348K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 6,002 | $339K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,205 | $326K |
| IQVIQVIA Holdings Inc. | 1,710 | $292K |
| PMPhilip Morris International Inc | 1,339 | $221K |
| UTHRUNITED THERAPEUTICS Corp | 372 | $221K |
| PFEPFIZER INC | 7,343 | $206K |
| AGLagilon health inc. | 11,290 | $89K |
| IRWDIRONWOOD PHARMACEUTICALS INC | 11,999 | $42K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.